| scholarly article | Q13442814 |
| P356 | DOI | 10.1378/CHEST.09-3082 |
| P953 | full work available at URL | http://intl.chestjournal.org/cgi/content/abstract/139/2/296 |
| https://api.elsevier.com/content/article/PII:S0012369211600688?httpAccept=text/plain | ||
| https://api.elsevier.com/content/article/PII:S0012369211600688?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 20671055 |
| P5875 | ResearchGate publication ID | 45423787 |
| P2093 | author name string | Nobuhisa Ishikawa | |
| Nobuoki Kohno | |||
| Akihito Yokoyama | |||
| Noboru Hattori | |||
| Taku Nakashima | |||
| Yoshinori Haruta | |||
| Jyunya Inata | |||
| P2860 | cites work | Trousseau's syndrome: multiple definitions and multiple mechanisms | Q28301882 |
| The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 | ||
| Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation | Q30442280 | ||
| Plasma C-reactive protein levels are associated with improved outcome in ARDS. | Q33637609 | ||
| Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation | Q34376495 | ||
| Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome | Q34515095 | ||
| Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. | Q34520692 | ||
| Prognostic value of an early soluble L-selectin (sCD62L) assay for risk assessment in blunt multiple trauma: a metaanalysis | Q35954072 | ||
| Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? | Q36497048 | ||
| Soluble L-selectin is present in human plasma at high levels and retains functional activity | Q36531941 | ||
| Selectins--potential pharmacological targets? | Q36630618 | ||
| Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome | Q36642046 | ||
| Epidemiology and outcomes of acute lung injury. | Q36734407 | ||
| Randomized clinical trial of activated protein C for the treatment of acute lung injury | Q36889970 | ||
| Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy | Q37607923 | ||
| Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas | Q39886779 | ||
| Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome. | Q40120539 | ||
| Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma | Q40172126 | ||
| Analysis of clinical risk factors associated with the prognosis of severe multiple-trauma patients with acute lung injury | Q44131098 | ||
| Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation | Q44189735 | ||
| Treatment of acute lung injury: clinical and experimental studies | Q46444097 | ||
| Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors. | Q46715482 | ||
| Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation | Q47859434 | ||
| KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. | Q48028199 | ||
| Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. | Q51655192 | ||
| Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. | Q51984024 | ||
| Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. | Q53546521 | ||
| Disseminated intravascular coagulation | Q55891311 | ||
| Role of selectiris In development of adult respiratory distress syndrome | Q64461814 | ||
| New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 | Q69510700 | ||
| KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease | Q72918027 | ||
| Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis | Q77563835 | ||
| Role of P-selectin and PSGL-1 in coagulation and thrombosis | Q80534641 | ||
| Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation | Q81641908 | ||
| Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury | Q83221910 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute respiratory distress syndrome | Q344873 |
| disseminated intravascular coagulation | Q823027 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 296-304 | |
| P577 | publication date | 2010-07-29 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Mucins Carrying Selectin Ligands as Predictive Biomarkers of Disseminated Intravascular Coagulation Complication in ARDS | |
| P478 | volume | 139 |
| Q45293217 | A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup? |
| Q35100674 | Biomarkers in acute lung injury--marking forward progress |
| Q35291972 | Circulating markers of interstitial lung disease and subsequent risk of lung cancer |
| Q52722988 | Neutrophil-to-lymphocyte ratio as a prognostic marker in acute respiratory distress syndrome patients: a retrospective study. |
Search more.